Hi Sano
Well let’s see: Looking at my stocks, Schwab rated:
D – AMBA, BOFI, SNCR
C – EPAM, INFN, SKX, SWKS, WAB
B – CELG
A - None
They didn’t rate the others. I don’t know what the heck they are rating, but apparently it has nothing to do with how well the company is doing or how well the stock does. Maybe you have to be really, REALLY, mediocre to get a good rating.
IBD ratings. First IBD Top 50 with is a list of fundamentally good grwoth stocks, but really ranked by relative strength, so not to be given too much credit. Their comments in parenthesis
AMBA#1 (extended after successful test of 10 week moving average)
SWKS#2 (in buying range from 102.87 buy point of flat base)
EPAM#11 (Extended but forming new base with possible buy point of 70.59)
CRTO#14 (more than 5% above buy point in cup shaped base)
no other on the RS list.
SWKS and EPAM in “Sector leaders” which highlight great growth stocks not too far from a “buy point”.
Yes, I know charts are irrelevant here
IBD’s primary aid is ranking a growth stocks fundamentals. 99 means it is in the top 99% of the stocks they follow (which is a large amount). They provide lots of detail on previous EPS and Sales growth and expected growth.
(Comp rating, a combo of several items)
ticket…COMP…EPS…RS…
AMBA…99…99…99
SKWS…99…99…98
EPAM…98…95…95
CRTO…97…98…92
CELG…99…97…81
SKX…99…75…98
WAB…94…93…83
BOFI
SNCR
INBK
(could not find the last 3 because the paper groups them by sectors instead of alphabetically and they only list the top 30 or so sectors.)
An article in 5/26 edition with headline
stocks with wide profit margins have big potential for success
On the list: AMBA, SWKS,
CYBR (which is one of my strong holdings this board should consider)
IBD also pays attention to accumulation/distribution numbers to help judge if the big boys are buying or selling over time.
At any rate, they seem better than Schwab.